Home/ Supplements/ Echinacea/ Children's Echinacea & Zinc Lozenjet

Children's Echinacea & Zinc Lozenjet

product on market Tablet or Pill Superior Source Safety: 90/100
90/100

This product looks safe

  • Contains proprietary blend — exact ingredient amounts not disclosed
  • 50% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Zinc is supported by moderate evidence for reducing the duration of common cold symptoms when administered early. The proprietary blend's effectiveness is less documented due to limited evidence coverage for this specific formulation. Overall, the ingredients maintain a high safety profile for intended use.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Contains proprietary blend — exact ingredient amounts not disclosed

Label

Product Label

Label for Children's Echinacea & Zinc Lozenjet
Open Full PDF View on NIH DSLD →
Details

Label Data

1 MicroLingual(R) Tablet(s)
Serving Size
60
Servings
Botanical with Nutrients
Product Type
50%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

1 mg (12.5% DV)
Within RDA (0.1× RDA) 263 studies (A:6, B:134)
Proprietary Blend
16.5 mg

Other Ingredients

Lactose natural Peppermint flavor Acacia
Claims

Label Claims — Verification

Unverified All Other
Info

Product Information

Directions for Use

Directions: As a dietary supplement, for children less than 4 dissolve one MicroLingual tablet in meal or use as directed by your child's primary healthcare provider. For adults and children 4 or more years of age dissolve one MicroLingual tablet under the tongue daily. This product may also be swallowed by adults.

Warnings & Precautions

Warning: Keep out of reach of children.

Additional Information

ITEM # 90120 30775 P01 R04

Metadata

Product Details

DSLD Entry Date2017-01-25
Product TypeBotanical with Nutrients
FormTablet or Pill
DSLD ID69513
Data Updated2026-04-11
Research

Research Evidence

38
Research Sources
52
Avg Quality
15
Meta Analysis
12
Systematic Review
6
Rct
2
Clinical Trial
1
Regulatory Source
1
Openfda Safety
A Echinacea for preventing and treating the common cold
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
B Efficacy and safety of Echinacea purpurea in treating upper respiratory infections and complications of otitis media in children: Systematic review and meta-analysis
Meta Analysis Clinical nutrition ESPEN 2025 PubMed DOI
B Echinacea for preventing and treating the common cold
Systematic Review The Cochrane database of systematic reviews 2000 PubMed
B Echinacea Supplementation Does Not Impact Aerobic Capacity and Erythropoiesis in Athletes: A Meta-Analysis
Meta Analysis Nutrients 2024 PubMed DOI
B Echinacea for preventing and treating the common cold
Meta Analysis The Cochrane database of systematic reviews 2006 PubMed
B Therapeutic Potential of a Natural Blend of Aronia melancarpa, Lonicera caerulea, and Echinacea purpurea Extracts in Treating Upper Respiratory Tract Infections: Preliminary Clinical and In Vitro Immunomodulatory Insights
Rct International journal of molecular sciences 2024 PubMed DOI
B Herbal Medicine in Children With Respiratory Tract Infection: Systematic Review and Meta-Analysis
Meta Analysis Academic pediatrics 2018 PubMed DOI
B Evaluation of echinacea for the prevention and treatment of the common cold: a meta-analysis
Meta Analysis The Lancet. Infectious diseases 2007 PubMed
B Herbal Medicine for Cough: a Systematic Review and Meta-Analysis
Meta Analysis Forschende Komplementarmedizin (2006) 2015 PubMed DOI
B Echinacea for the prevention and treatment of upper respiratory tract infections: A systematic review and meta-analysis
Meta Analysis Complementary therapies in medicine 2019 PubMed DOI
View all evidence for Echinacea →
Compare

Similar Products

View all Echinacea products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.